429 related articles for article (PubMed ID: 33492244)
1. Parkinson's Disease and the COVID-19 Pandemic.
Fearon C; Fasano A
J Parkinsons Dis; 2021; 11(2):431-444. PubMed ID: 33492244
[TBL] [Abstract][Full Text] [Related]
2. The Influence of Coronavirus Disease-2019 (COVID-19) On Parkinson's Disease: An Updated Systematic Review.
Jaiswal V; Alquraish D; Sarfraz Z; Sarfraz A; Nagpal S; Singh Shrestha P; Mukherjee D; Guntipalli P; Sánchez Velazco DF; Bhatnagar A; Savani S; Halilaj E; Ruxmohan S; Cueva W
J Prim Care Community Health; 2021; 12():21501327211039709. PubMed ID: 34404266
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 and Parkinson's Disease: What Do We Know So Far?
Artusi CA; Romagnolo A; Ledda C; Zibetti M; Rizzone MG; Montanaro E; Bozzali M; Lopiano L
J Parkinsons Dis; 2021; 11(2):445-454. PubMed ID: 33749619
[TBL] [Abstract][Full Text] [Related]
4. Covid-19 and Parkinson's disease: Acute clinical implications, long-COVID and post-COVID-19 parkinsonism.
Leta V; Boura I; van Wamelen DJ; Rodriguez-Violante M; Antonini A; Chaudhuri KR
Int Rev Neurobiol; 2022; 165():63-89. PubMed ID: 36208907
[TBL] [Abstract][Full Text] [Related]
5. The impact of SARS-COV2 infection on people in residential care with Parkinson Disease or parkinsonisms: Clinical case series study.
Sorbera C; Brigandì A; Cimino V; Bonanno L; Ciurleo R; Bramanti P; Di Lorenzo G; Marino S
PLoS One; 2021; 16(5):e0251313. PubMed ID: 33956891
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and impact of COVID-19 in Parkinson's disease: evidence from a multi-center survey in Tuscany region.
Del Prete E; Francesconi A; Palermo G; Mazzucchi S; Frosini D; Morganti R; Coleschi P; Raglione LM; Vanni P; Ramat S; Novelli A; Napolitano A; Battisti C; Giuntini M; Rossi C; Menichetti C; Ulivelli M; De Franco V; Rossi S; Bonuccelli U; Ceravolo R;
J Neurol; 2021 Apr; 268(4):1179-1187. PubMed ID: 32880722
[TBL] [Abstract][Full Text] [Related]
7. Viruses, parkinsonism and Parkinson's disease: the past, present and future.
Leta V; Urso D; Batzu L; Lau YH; Mathew D; Boura I; Raeder V; Falup-Pecurariu C; van Wamelen D; Ray Chaudhuri K
J Neural Transm (Vienna); 2022 Sep; 129(9):1119-1132. PubMed ID: 36036863
[TBL] [Abstract][Full Text] [Related]
8. The impact of COVID-19 on palliative care for people with Parkinson's and response to future pandemics.
Chaudhuri KR; Rukavina K; McConvey V; Antonini A; Lorenzl S; Bhidayasiri R; Piemonte MEP; Lim SY; Richfield E; Walker R; Bouca-Machado R; Bajwah S; Gao W; Trivedi D; Miyasaki J
Expert Rev Neurother; 2021 Jun; 21(6):615-623. PubMed ID: 33905283
[No Abstract] [Full Text] [Related]
9. COVID-19 manifestations in people with Parkinson's disease: a USA cohort.
Xu Y; Surface M; Chan AK; Halpern J; Vanegas-Arroyave N; Ford B; Feeney MP; Kwei KT; Katus LE; Kuo SH; Shah H; Waters C; Winfield LM; Beck JC; Przedborski S; Fahn S; Alcalay RN
J Neurol; 2022 Mar; 269(3):1107-1113. PubMed ID: 34482434
[TBL] [Abstract][Full Text] [Related]
10. [Risk and course of COVID-19 in patients with Parkinson's disease].
Zalyalova ZA; Khasanova DM
Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(9):152-156. PubMed ID: 34693704
[TBL] [Abstract][Full Text] [Related]
11. The impact of Parkinson's disease on manifestations and outcomes of Covid-19 patients: A systematic review and meta-analysis.
El-Qushayri AE; Ghozy S; Reda A; Kamel AMA; Abbas AS; Dmytriw AA
Rev Med Virol; 2022 Mar; 32(2):e2278. PubMed ID: 34260773
[TBL] [Abstract][Full Text] [Related]
12. The changes of exercise pattern and clinical symptoms in patients with Parkinson's disease in the era of COVID-19 pandemic.
Song J; Ahn JH; Choi I; Mun JK; Cho JW; Youn J
Parkinsonism Relat Disord; 2020 Nov; 80():148-151. PubMed ID: 33002722
[TBL] [Abstract][Full Text] [Related]
13. Links between COVID-19 and Parkinson's disease/Alzheimer's disease: reciprocal impacts, medical care strategies and underlying mechanisms.
Huang P; Zhang LY; Tan YY; Chen SD
Transl Neurodegener; 2023 Jan; 12(1):5. PubMed ID: 36717892
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 and Parkinson's Disease: A Review of Where We Are Now.
Boura I; Qamar MA; Daddoveri F; Leta V; Poplawska-Domaszewicz K; Falup-Pecurariu C; Ray Chaudhuri K
Biomedicines; 2023 Sep; 11(9):. PubMed ID: 37760965
[TBL] [Abstract][Full Text] [Related]
15. [The questionnaire survey regarding the impact of COVID-19 pandemic on Parkinson's disease patients].
Tezuka T; Osada T; Terayama Y; Kubota M; Okusa S; Shiihashi G; Kubo SI; Suzuki N; Nakahara J; Seki M
Rinsho Shinkeigaku; 2022 Jan; 62(1):8-14. PubMed ID: 34924470
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and outcomes of hospitalised patients with COVID-19 and Parkinsonian disorders: A multicentre UK-based study.
Sorrell L; Leta V; Barnett A; Stevens K; King A; Inches J; Kobylecki C; Walker R; Chaudhuri KR; Martin H; Rideout J; Sneyd JR; Campbell S; Carroll C;
PLoS One; 2023; 18(7):e0285349. PubMed ID: 37523365
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2, COVID-19 and Parkinson's Disease-Many Issues Need to Be Clarified-A Critical Review.
Goerttler T; Kwon EH; Fleischer M; Stettner M; Tönges L; Klebe S
Brain Sci; 2022 Mar; 12(4):. PubMed ID: 35447986
[TBL] [Abstract][Full Text] [Related]
18. Clinical Profiles and Mortality of COVID-19 Inpatients with Parkinson's Disease in Germany.
Scherbaum R; Kwon EH; Richter D; Bartig D; Gold R; Krogias C; Tönges L
Mov Disord; 2021 May; 36(5):1049-1057. PubMed ID: 33942924
[TBL] [Abstract][Full Text] [Related]
19. Unexplained worsening of parkinsonian symptoms in a patient with advanced Parkinson's disease as the sole initial presentation of COVID-19 infection: a case report.
Kamel WA; Ismail II; Ibrahim M; Al-Hashel JY
Egypt J Neurol Psychiatr Neurosurg; 2021; 57(1):60. PubMed ID: 34025113
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and outcomes of Covid-19 in Parkinson's disease: Acute settings and hospital.
Fearon C; Fasano A
Int Rev Neurobiol; 2022; 165():35-62. PubMed ID: 36208906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
